The ASX 200 has bounced back following a $25 billion wipeout on Wednesday triggered by Donald Trump escalating his trade war ...

Johnson & Johnson (NYSE:JNJ) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with adjusted EPS of $2.77 and net earnings of $5.5 billion. Management raised ...

Windtree Therapeutics signs $60M deal for BNB treasury strategy, becoming the first Nasdaq firm to offer direct exposure to ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth ...

Stocks were taken on a wild ride Wednesday as a White House official indicated to CNBC that Trump was moving closer to firing ...

Is it safe to get into the water? If "Jaws" taught us anything, it was to be cautious of your surroundings before going for a ...

SpaceX is planning a stock sale for employees and investors at a per-share price of $212, up from $185 in December, Bloomberg ...

Bank of America reported second-quarter fiscal 2025 net income of $7.1 billion (versus $6.9 billion a year ago) and EPS of $0 ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

Lilly, Johnson & Johnson, AbbVie, Pfizer and more pharma stocks shrug even amid Trump's fresh pharma tariff threats.